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TECHNICAL REPORT
PASTEURIZATION OF HUMAN MILK TO PREVENT TRANSMISSION OF CHAGAS DISEASE
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SUMMARY
Although admittedly transmission of Trypanosoma cruzi infection through breastfeeding is a rare event, it involves serious risks.
To test the effectiveness of pasteurization in preventing this mode of infection, three sets of samples of human milk were tested: a –
contaminated with T. cruzi and pasteurized; b – contaminated with T. cruzi and non-pasteurized; c – non-contaminated and pasteurized.
Samples from all sets were orally and intraperitoneally administered to 90 BALB/c mice. The animals inoculated with contaminated,
non-pasteurized samples, got the infection. Controls and the animals inoculated with contaminated and pasteurized milk were not
infected.  The hypothesis was accepted that pasteurization inactivates T. cruzi trypomastigotes.
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Control of populations of Trypanosoma cruzi vectors, to a large extent
achieved in Brazil, was followed by a marked reduction in the frequency
of new cases of Chagas disease. Alternative modes of transmission,
breastfeeding among them, were thus put to the foreground. MAZZA et
al6. reported in 1936 the first finding of T. cruzi in human milk, namely
from a patient in the acute phase of Chagas disease. DISKO &
KRAMPITZ5 (1971) observed numerous T. cruzi trypomastigotes in the
milk of experimentally infected mice and pointed out that this was not
due to contamination of milk with blood from ruptured vessels. However,
they were unable to demonstrate the infection of suckling mice via
contaminated milk. Likewise, CAMPOS et al.4 found that experimentally
infected female mice failed to infect their litters through suckling. MILES9
(1972) detected T. cruzi trypomastigotes and anti-T. cruzi antibodies in
the milk of mice in the acute phase of the infection. MEDINA-LOPES7,8
reported in 1983 and 1988, respectively, two cases of infants, born of
infected mothers, who developed acute Chagas disease while being
breastfed, which was attributed to the ingestion of blood from papillary
fissures. BITTENCOURT et al.3 (1988) and AMATO NETO et al.2 (1992)
could not demonstrate the presence of T. cruzi in the milk of infected
mothers. AMATO NETO et al.1 (1999) evaluated experimentally the
penetration, through the digestive tract, of  T. cruzi trypomastigotes
suspended in liquid foods. Although admittedly it is a rare event, human
to human transmission of T. cruzi through breastfeeding must be
prevented whenever possible. Accordingly, infected women reaching
fertile age should be regarded as a potential health hazard to their
offspring. One should not underestimate the risk of transmission from
infected nursing mothers who, possibly unaware of their condition, are
also milk bank donors. This risk obviously increases when the mothers
involved are in the acute phase of the infection.
Pasteurization inactivates the causative agents of many diseases
(including HIV)10, in which case it will not be necessary to deprive infants
of their mother’s milk. To evaluate the effectiveness of pasteurization in
inactivating T. cruzi trypomastigotes suspended in human milk, an
experiment was set up. A volume of 50 mL of human milk from a healthy
donor, kindly supplied by the Milk Bank of Hospital Estadual Infantil
“Darcy Vargas”, kept at the temperature of  –18 ºC until used, was divided
into 5 samples. To samples 1, 2, 3 and 4 respectively, we added 2,500,
5,000, 10,000 and 2,500 T. cruzi trypomastigotes (Y strain) from
laboratory-infected BALB/c mice. No contaminated material was added
to sample 5. Samples 1, 2, 3 and 5 were pasteurized by immersion in a
water bath at 62.5 ºC during 30 minutes, and then in melting ice for 10
minutes. We used ten batches of mice (A, B, C, D, E, F, G, H, I, and J),
supplied by the Laboratory Animal Facilitiy Center, Faculty of Medicine
of the University of São Paulo. Batches A to H were composed of ten
mice, I and J of 5 mice each. The milk samples were administered orally
and intraperitoneally to the animals, as described in Table 1. Starting
from the 5th day of administration, fresh preparations of peripheral blood
from each animal were examined (400× magnification) at 3-day intervals
during 60 days. As shown in Table 1, positive results were observed
only in the animals to which non-pasteurized, contaminated milk was
given, thus confirming the hypothesis of the effectiveness of human milk
pasteurization in inactivating suspended T. cruzi trypomastigotes. As
the nutritional value of the milk is mostly preserved after pasteurization,
and the process is quite simple, its use is recommended whenever the
mother is presumed infected.
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RESUMO
Pasteurização de leite humano para evitar a transmissão da
doença de Chagas
A amamentação é modo alternativo de transmitir-se a doença de
Chagas. Embora admitida como evento raro, a infecção por esta via é
preocupante. Para evitá-la é sugerida a pasteurização. Separaram-se para
o ensaio três conjuntos de amostras de leite humano: a – contaminadas
por Trypanosoma cruzi e pasteurizadas; b – contaminadas por T. cruzi e
não pasteurizadas; c – não contaminadas e pasteurizadas. Frações dos
três conjuntos foram inoculadas por vias oral e intraperitoneal em 90
camundongos BALB/c. Os animais inoculados com leite contaminado e
não pasteurizado infectaram-se. Os controles e os inoculados com leite
contaminado e pasteurizado não se infectaram. Aceitou-se a hipótese de
a pasteurização ter inativado as formas tripomastigotas de T. cruzi em
suspensão no leite.
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Table 1
Results of search for Trypanosoma cruzi trypomastigotes in the peripheral blood of BALB/c mice inoculated according with the experimental conditions described
Batch Number of animals Milk sample Parasites per mL Volume (mL) Administration Result
A 10 1   250 0.1  Oral Negative
B 10 1   250 0.5   Intraperitoneal Negative
C 10 2   500 0.1  Oral Negative
D 10 2   500 0.5   Intraperitoneal Negative
E 10 3   1,000 0.1  Oral Negative
F 10 3   1,000 0.5   Intraperitoneal Negative
G 10 4 * 250 0.1  Oral Positive
H 10 4 * 250 0.5   Intraperitoneal Positive
I 5 5   0 0.1  Oral Negative
J 5 5   0 0.5   Intraperitoneal Negative
* Non-pasteurized
